Bjarke Abrahamsen

2.9k total citations · 1 hit paper
29 papers, 2.3k citations indexed

About

Bjarke Abrahamsen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Bjarke Abrahamsen has authored 29 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 11 papers in Physiology. Recurrent topics in Bjarke Abrahamsen's work include Neuroscience and Neuropharmacology Research (13 papers), Pain Mechanisms and Treatments (10 papers) and Receptor Mechanisms and Signaling (10 papers). Bjarke Abrahamsen is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Pain Mechanisms and Treatments (10 papers) and Receptor Mechanisms and Signaling (10 papers). Bjarke Abrahamsen collaborates with scholars based in Denmark, United Kingdom and Germany. Bjarke Abrahamsen's co-authors include John N. Wood, Mark D. Baker, Mohammed A. Nassar, Jing Zhao, Curtis O. Asante, R. Mark Gardiner, Frances Elmslie, Keith A. Parker, Anthony H. Dickenson and Norbert Klugbauer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Bjarke Abrahamsen

29 papers receiving 2.2k citations

Hit Papers

SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Alle... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers

Bjarke Abrahamsen
Stefanie A. Kane United States
James Offord United States
Ti‐Zhi Su United States
Ethan S. Burstein United States
Kenneth S. Koblan United States
Tony Priestley United States
Bjarke Abrahamsen
Citations per year, relative to Bjarke Abrahamsen Bjarke Abrahamsen (= 1×) peers Jiřı́ Paleček

Countries citing papers authored by Bjarke Abrahamsen

Since Specialization
Citations

This map shows the geographic impact of Bjarke Abrahamsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjarke Abrahamsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjarke Abrahamsen more than expected).

Fields of papers citing papers by Bjarke Abrahamsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjarke Abrahamsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjarke Abrahamsen. The network helps show where Bjarke Abrahamsen may publish in the future.

Co-authorship network of co-authors of Bjarke Abrahamsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bjarke Abrahamsen. A scholar is included among the top collaborators of Bjarke Abrahamsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjarke Abrahamsen. Bjarke Abrahamsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abrahamsen, Bjarke, et al.. (2022). Mapping of Danish Pharmacy Technician Students’ Third-Year Projects in a Year with the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 10(1). 33–33. 1 indexed citations
2.
Abrahamsen, Bjarke, et al.. (2020). Pharmaceutical care services available in Danish community pharmacies. International Journal of Clinical Pharmacy. 42(2). 315–320. 28 indexed citations
3.
Abrahamsen, Bjarke, et al.. (2020). For which patient subgroups does exist positive outcomes from a medication review? A systematic review. Pharmacy Practice. 18(4). 1976–1976. 7 indexed citations
4.
Abrahamsen, Bjarke, et al.. (2019). Customers’ information seeking behavior prior to community pharmacy visits: A community pharmacy survey. Research in Social and Administrative Pharmacy. 16(10). 1442–1446. 5 indexed citations
5.
Hansen, Stinne W., Mette N. Erichsen, Tri H. V. Huynh, et al.. (2016). New Insight into the Structure–Activity Relationships of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors UCPH‐101 and UCPH‐102. ChemMedChem. 11(4). 382–402. 5 indexed citations
7.
Abrahamsen, Bjarke, Nicole Schneider, Mette N. Erichsen, et al.. (2013). Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain. Journal of Neuroscience. 33(3). 1068–1087. 52 indexed citations
8.
Venskutonytė, Raminta, Bjarke Abrahamsen, Birgitte Nielsen, et al.. (2013). Chemoenzymatic Synthesis of New 2,4-syn-Functionalized (S)-Glutamate Analogues and Structure–Activity Relationship Studies at Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters. Journal of Medicinal Chemistry. 56(4). 1614–1628. 37 indexed citations
9.
Jungblut, Melanie, Serena Barral, Bjarke Abrahamsen, et al.. (2012). Isolation and characterization of living primary astroglial cells using the new GLAST‐specific monoclonal antibody ACSA‐1. Glia. 60(6). 894–907. 59 indexed citations
10.
Huynh, Tri H. V., Bjarke Abrahamsen, Karsten K. Madsen, et al.. (2012). Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102. Bioorganic & Medicinal Chemistry. 20(23). 6831–6839. 38 indexed citations
11.
Bjerrum, Ole J., et al.. (2011). Effects of the excitatory amino acid transporter subtype 2 (EAAT-2) inducerceftriaxone on different pain modalities in rat. Scandinavian Journal of Pain. 2(3). 132–136. 15 indexed citations
12.
Zhao, Jing, Ali Momin, Cruz Miguel Cendán, et al.. (2010). Small RNAs Control Sodium Channel Expression, Nociceptor Excitability, and Pain Thresholds. Journal of Neuroscience. 30(32). 10860–10871. 141 indexed citations
13.
Lagerström, Malin C., Katarzyna Rogóż, Bjarke Abrahamsen, et al.. (2010). VGLUT2-Dependent Sensory Neurons in the TRPV1 Population Regulate Pain and Itch. Neuron. 68(3). 529–542. 166 indexed citations
14.
Abrahamsen, Bjarke, Jing Zhao, Curtis O. Asante, et al.. (2008). The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain. Science. 321(5889). 702–705. 382 indexed citations
15.
Ekberg, Jenny, Christopher W. Vaughan, Sevda C. Aslan, et al.. (2006). μO-conotoxin MrVIB selectively blocks Na v 1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proceedings of the National Academy of Sciences. 103(45). 17030–17035. 161 indexed citations
16.
Fertleman, Caroline, Mark D. Baker, Keith A. Parker, et al.. (2006). SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes. Neuron. 52(5). 767–774. 559 indexed citations breakdown →
17.
Wood, John N., Bjarke Abrahamsen, Mark D. Baker, et al.. (2004). Ion Channel Activities Implicated in Pathological Pain. Novartis Foundation symposium. 261. 32–46. 30 indexed citations
19.
Jensen, Anders A., Johannes Mosbacher, Susanne Elg, et al.. (2002). The Anticonvulsant Gabapentin (Neurontin) Does Not Act through γ-Aminobutyric Acid-B Receptors. Molecular Pharmacology. 61(6). 1377–1384. 3 indexed citations
20.
Jensen, Anders A., Johannes Mosbacher, Susanne Elg, et al.. (2002). The Anticonvulsant Gabapentin (Neurontin) Does Not Act through γ-Aminobutyric Acid-B Receptors. Molecular Pharmacology. 61(6). 1377–1384. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026